Influenza Virus Neuraminidase: Structure, Evolution and Therapeutics

A special issue of Viruses (ISSN 1999-4915). This special issue belongs to the section "Animal Viruses".

Deadline for manuscript submissions: 20 December 2024 | Viewed by 69

Special Issue Editors


E-Mail Website
Guest Editor
Antiviral Resistance Lab, Research & Development Unit, Infectious Diseases Department, Instituto Nacional de Saúde Doutor Ricardo Jorge, Lisbon, Portugal
Interests: merging infectious diseases; respiratory viruses; influenza; SARS-CoV-2; flavivirus; antiviral research; infectious disease epidemiology; infectious disease surveillance; antiviral resistance; epidemiological surveillance; influenza vaccines; epidemiology and public health; medical microbiology; infectious diseases; molecular epidemiology; genetic engineering; antimicrobials; epidemiology; genetic epidemiology

E-Mail Website
Guest Editor
Antiviral Resistance Lab, Research & Development Unit, Infectious Diseases Department, Instituto Nacional de Saúde Doutor Ricardo Jorge, Lisbon, Portugal
Interests: infectious diseases; virology; influenza; SARS-CoV-2; flavivirus; antiviral research; antiviral resistance; new antiviral targets and compounds; molecular virology; evolution and genetic diversity; bioinformatics and computational biology

Special Issue Information

Dear Colleagues,

This Special Issue, entitled “Influenza Virus Neuraminidase: Structure, Evolution, and Therapeutics”, aims to present recent research on several aspects of influenza neuraminidase (NA). Some of its focal points include, but are not limited to, the following:

  1. Protein structure;
  2. Genetic evolutionary changes and pathways;
  3. Selective pressure;
  4. Targeted antivirals: licensed and novel approaches/inhibitors;
  5. Antiviral resistance and reduced susceptibility;
  6. NA-based monoclonal antibodies;
  7. NA as a vaccine antigen.

Reviews, original research articles, brief reports, and communications from academia, research institutes, or industries are welcome.

Dr. Helena Rebelo-De-Andrade
Dr. Vanessa Correia
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Viruses is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • influenza neuraminidase
  • viral antigen
  • human and zoonotic influenza viruses
  • protein structure
  • evolution
  • antiviral therapies
  • vaccine target

Published Papers

This special issue is now open for submission.
Back to TopTop